The IN.PACT™ AV drug-coated balloon (DCB) enables you to get ahead of AV fistula restenosis by treating the cause — not just the symptoms — of fistula stenosis, helping to preserve the fistula for dialysis.1 It's the only device to achieve more than 80% primary patency† through six months.
The IN.PACT™ AV paclitaxel-coated PTA balloon is indicated for percutaneous transluminal angioplasty, after appropriate vessel preparation, for the treatment of obstructive lesions up to 100 mm in length in the native arteriovenous dialysis fistulae with reference vessel diameters of 4 mm to 12 mm.
† Target lesion primary patency in an AV fistula IDE randomized controlled trial.
Find more information, including other available configurations, for IN.PACT™ AV drug-coated balloon.